Top 4 Under Valued Stocks in the Medical Sector
By:NewsyStocks   Tuesday, August 09, 2021 1:36 PM



Hanger Orthopedic Group Inc. (NYSE: HGR) is a provider of services and products that enhance human physical capabilities. The company has market capitalization of $593.7 million. Its five year projected EPS growth at 15 percent. Trailing twelve month (TTM) diluted EPS at $0.87. The stock is trading at a discount of 38.88 percent, which indicates high potential to increase in value. This is a less volatile stock that is than the overall market with a beta of just 0.4. The stock is currently stuck in a downtrend, trading 31.6 percent below its price on May 23, 2022 of $24.62, that's when SmartTrend identified a downtrend for the stock. It's been a rough couple of weeks for the stock, losing 32 percent. Analysts at Wall Street have given a strong buy rating on the stock. The stock is currently trading higher by 4.63 percent to $17.62 a share.

Health Management Associates Inc. (NYSE: HMA) through its subsidiaries, operates general acute care hospitals in non-urban communities. The company has market capitalization of $2 billion. Its five year projected EPS growth at 12 percent. Trailing twelve month (TTM) diluted EPS at $0.66. The stock is trading at a discount of 37.74 percent, which indicates potential to increase in value. This is a risky stock that is significantly more volatile than the overall market with a beta of 2.2. The stock is currently stuck in a downtrend, trading much lower than the SMA of 50, 100, and 200 days suggest. In the last 1-month the stock has lost about 40 percent in value. Analysts at Wall Street have given a buy rating on the stock. The stock is currently trading higher by 8.08 percent to $7.36 a share.

Abaxis Inc. (Nasdaq: ABAX) develops, manufactures, markets and sells portable blood analysis systems for use in any human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The company has market capitalization of $474.8 million. Its five year projected EPS growth at 16.67 percent. Trailing twelve month (TTM) diluted EPS at $0.58. The stock is trading at a discount of 31.80 percent, which indicates potential to increase in value. This is a less risky stock that is as much volatile as the overall market with a beta of 1.1. The company announced its $40 million share repurchase program on August 8, 2011. In the last 1-month the stock has lost about 34 percent in value. Analysts at Wall Street have given a buy rating on the stock. The stock is currently trading higher by 4.20 percent to $20.83 a share.

Sonosite Inc. (Nasdaq: SONO) specializes in the development of hand-carried ultrasound (HCU) systems for use in a variety of medical specialties in a range of clinical settings. The company has market capitalization of $398.5 million. Its five year projected EPS growth at 20 percent. Trailing twelve month (TTM) diluted EPS at $0.47. The stock is trading at a discount of 28.15 percent, which indicates potential to increase in value. This is a less risky stock that is as much volatile as the overall market with a beta of 1. The stock is currently stuck in a downtrend, trading much lower than the SMA of 50, 100, and 200 days suggest. In the last 1-month the stock has lost about 23 percent in value. Analysts at Wall Street have given a strong buy rating on the stock. The stock is currently trading higher by 4.56 percent to $28.64 a share.


 

Sponsors

Advertisement


Advertisement